Journal of Pharmacogenomics & Pharmacoproteomics

Challenges of molecular diagnostics innovation system development in India

4^th International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics

September 22-23, 2016 Phoenix, USA

Nidhi Singh

Jawaharlal Nehru University, India

Posters & Accepted Abstracts: J Pharmacogenomics Pharmacoproteomics

Abstract:

Molecular diagnostics is emerging technological innovation system in India. It has lot of potential which can improve diagnostic practices and healthcare outcome but practice of innovation-making for system development in respect of molecular diagnostics is facing substantial obstacles and misaligned incentives in India. This study through empirical analysis finds India being a latecomer country in the field of molecular biology research and has not been able to keep up with the worldwide pace of development of technological innovation system. Investigations also indicate dependence on imports in the supply of molecular diagnostics has meant high prices due to which these tests are unaffordable and also therefore unavailable to majority of population. Recently few domestic start-up firms have begun taking interest for developing molecular biomarkers for tropical diseases but their overall market share as compared to foreign firms is quite insignificant. Study also suggests that lack in capability for macular diagnostic development in India results from failures occurring at discovery research as well as technology development. Therefore, it is suggested that India should undertake a responsible innovation framework for the development and diffusion of this emerging diagnostic technologies to look after the country specific social, legal and ethical diagnostic challenges of innovation making. Responsible innovation approach would provide long term sustainability for technological developments which can contribute to morally desirable and socially acceptable diagnostic practices.

Biography :

Email: nidhisinghb8@gmail.com